
Versigent rose 47.7% from $27.85 to $41.14, ahead of the S&P 500's +12.9%. Its worst day was Jul 7 (−6.4%), and its low came Apr 7 at $26.94.
Apr 1, 2026 – Nov 16, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Versigent closed at its lowest level of the year, 3.3% below where the year started.
−4.9% · S&P 500 0.0%
EPS of $1.10 was reported on $2.2B revenue; FY revenue guidance of $9.1B–$9.4B.
Story events cover the past 12 months · Times ET
+10.8%, the year's best day · S&P 500 +1.4%
Versigent shares rose 10.3%, while the S&P 500 fell 0.7%.
+10.3% · S&P 500 −0.7%
EPS of $1.92 beat the $1.51 estimate on $2.4B revenue (est. $2.3B); FY revenue guidance of $9.4B–$9.6B against the $9.3B consensus.
+8.9% · S&P 500 +1.8%
Versigent closed at its highest level of the year, 80.3% above where the year started.
+4.0% · S&P 500 −0.4%
EPS of $1.91 beat the $1.73 estimate on $2.5B revenue (est. $2.4B); FY revenue guidance of $9.5B–$9.6B against the $9.5B consensus.
+3.1% · S&P 500 +1.7%
Where it ended: a close of $41.14 on Nov 16, 2026. Up next: Q4 2026 earnings on Feb 5, 2027 (EPS est. $1.52, revenue est. $2.4B).
Nothing in the past 12 months.
All VGNT dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for VGNT and SPY from Benzinga historical bars. Not investment advice.